|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 May 2001, Vol. 97, No. 10, pp. 3205-3209
NEOPLASIA
Association between polymorphisms of folate- and
methionine-metabolizing enzymes and susceptibility to
malignant lymphoma
Keitaro Matsuo,
Ritsuro Suzuki,
Nobuyuki Hamajima,
Michinori Ogura,
Yoshitoyo Kagami,
Hirofumi Taji,
Eisei Kondoh,
Satoko Maeda,
Shoji Asakura,
Sadayuki Kaba,
Shigeo Nakamura,
Masao Seto,
Yasuo Morishima, and
Kazuo Tajima
From the Divisions of Epidemiology and Prevention,
Molecular Medicine, and Pathology and Genetics, the Departments of
Hematology and Chemotherapy, and the Clinical Laboratory, Aichi Cancer
Center; and the Nagoya University Graduate School of Medicine, Japan.
Genetic alteration is considered a probable cause of malignant
lymphoma. Folate and methionine metabolism play essential roles in DNA
synthesis and DNA methylation, and their metabolic pathways might thus
affect disease susceptibility. In the present study, 2 polymorphisms
were evaluated for a folate metabolic enzyme, methylenetetrahydrofolate
reductase (MTHFR), and one was evaluated for methionine synthase (MS).
The 2 polymorphisms, MTHFR677 C T and MTHFR1298 A C, are reported
to reduce the enzyme activity, which causes intracellular accumulation
of 5,10-methylenetetrahydrofolate and results in a reduced incidence of
DNA double-strand breakage. The MS2756 A G polymorphism also reduces
the enzyme activity and results in the hypomethylation of DNA. To
evaluate the association between malignant lymphoma susceptibility and
these polymorphisms, hospital-based case-control study was conducted in
Aichi Cancer Center. Ninety-eight patients with histologically
confirmed lymphoma and 243 control subjects without cancer were
evaluated. Unconditional logistic regression analyses revealed a higher
susceptibility with the MTHFR677 CC and the MTHFR1298 AA genotypes
(odds ratio, 2.26; 95% confidence interval, 1.26-4.02) when those
harboring at least one variant allele in either polymorphism of MTHFR
were defined as the reference. For the MS polymorphism, the MS2756 GG
genotype also showed a higher susceptibility (odds ratio, 3.83; 95%
CI, 1.21-12.1) than those with MS2756 AA or AG types. The significance
was not altered when these 3 polymorphisms were evaluated in
combination, and the results suggest that folate and methionine metabolism play important roles in the occurrence of malignant lymphomas. Further studies to confirm the association and detailed biologic mechanisms are now required.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Collin, C. Metcalfe, L. Zuccolo, S. J. Lewis, L. Chen, A. Cox, M. Davis, J. A. Lane, J. Donovan, G. D. Smith, et al.
Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysis
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2009;
18(9):
2528 - 2539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. de Jonge, W. J. E. Tissing, J. H. Hooijberg, G. Jansen, G. J. L. Kaspers, J. Lindemans, G. J. Peters, and R. Pieters
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia
Blood,
March 5, 2009;
113(10):
2284 - 2289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Kristensen and A. Dobrovic
Direct Genotyping of Single Nucleotide Polymorphisms in Methyl Metabolism Genes Using Probe-Free High-Resolution Melting Analysis
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2008;
17(5):
1240 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koutros, Y. Zhang, Y. Zhu, S. T. Mayne, S. H. Zahm, T. R. Holford, B. P. Leaderer, P. Boyle, and T. Zheng
Nutrients Contributing to One-Carbon Metabolism and Risk of Non-Hodgkin Lymphoma Subtypes
Am. J. Epidemiol.,
February 1, 2008;
167(3):
287 - 294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica,
July 1, 2007;
92(7):
960 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gemmati, A. Ongaro, S. Tognazzo, L. Catozzi, F. Federici, E. Mauro, M. Della Porta, D. Campioni, A. Bardi, G. Gilli, et al.
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival
Haematologica,
April 1, 2007;
92(4):
478 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lim, S. S. Wang, P. Hartge, W. Cozen, L. E. Kelemen, S. Chanock, S. Davis, A. Blair, M. Schenk, N. Rothman, et al.
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study
Blood,
April 1, 2007;
109(7):
3050 - 3059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Niclot, Q. Pruvot, C. Besson, D. Savoy, E. Macintyre, G. Salles, N. Brousse, B. Varet, P. Landais, P. Taupin, et al.
Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas
Blood,
July 1, 2006;
108(1):
278 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Lightfoot, C. F. Skibola, E. V. Willett, D. R. Skibola, J. M. Allan, F. Coppede, P. J. Adamson, G. J. Morgan, E. Roman, and M. T. Smith
Risk of Non-Hodgkin Lymphoma Associated with Polymorphisms in Folate-Metabolizing Genes
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2005;
14(12):
2999 - 3003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Justenhoven, U. Hamann, C. B. Pierl, S. Rabstein, B. Pesch, V. Harth, C. Baisch, C. Vollmert, T. Illig, T. Bruning, et al.
One-Carbon Metabolism and Breast Cancer Risk: No Association of MTHFR, MTR, and TYMS Polymorphisms in the GENICA Study from Germany
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2005;
14(12):
3015 - 3018.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matsuo, H. Ito, K. Wakai, K. Hirose, T. Saito, T. Suzuki, T. Kato, T. Hirai, Y. Kanemitsu, H. Hamajima, et al.
One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan
Carcinogenesis,
December 1, 2005;
26(12):
2164 - 2171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Lim, M. Schenk, L. E. Kelemen, S. Davis, W. Cozen, P. Hartge, M. H. Ward, and R. Stolzenberg-Solomon
Dietary Determinants of One-Carbon Metabolism and the Risk of Non-Hodgkin's Lymphoma: NCI-SEER Case-Control Study, 1998-2000
Am. J. Epidemiol.,
November 15, 2005;
162(10):
953 - 964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-X. Yang, K. Matsuo, H. Ito, M. Shinoda, S. Hatooka, K. Hirose, K. Wakai, T. Saito, T. Suzuki, T. Maeda, et al.
Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan
Carcinogenesis,
July 1, 2005;
26(7):
1285 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Li, M. Ahmed, Y. Li, L. Jiao, T.-H. Chou, R. A. Wolff, R. Lenzi, D. B. Evans, M. L. Bondy, P. W. Pisters, et al.
5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2005;
14(6):
1470 - 1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, Q. Shi, Z. Liu, E. M. Sturgis, M. R. Spitz, and Q. Wei
Polymorphisms of Methionine Synthase and Methionine Synthase Reductase and Risk of Squamous Cell Carcinoma of the Head and Neck: a Case-Control Analysis
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2005;
14(5):
1188 - 1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Friso, D. Girelli, E. Trabetti, O. Olivieri, P. Guarini, P. F. Pignatti, R. Corrocher, and S.-W. Choi
The MTHFR 1298A>C Polymorphism and Genomic DNA Methylation in Human Lymphocytes
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2005;
14(4):
938 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stanulla, K. Seidemann, E. Schnakenberg, M. Book, A. Mehles, K. Welte, M. Schrappe, and A. Reiter
Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population
Blood,
January 15, 2005;
105(2):
906 - 907.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ulvik, S. E. Vollset, S. Hansen, R. Gislefoss, E. Jellum, and P. M. Ueland
Colorectal Cancer and the Methylenetetrahydrofolate Reductase 677C -> T and Methionine Synthase 2756A -> G Polymorphisms: A Study of 2,168 Case-Control Pairs from the JANUS Cohort
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2004;
13(12):
2175 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Skibola, M. S. Forrest, F. Coppede, L. Agana, A. Hubbard, M. T. Smith, P. M. Bracci, and E. A. Holly
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma
Blood,
October 1, 2004;
104(7):
2155 - 2162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lin, M. R. Spitz, Y. Wang, M. B. Schabath, I. P. Gorlov, L. M. Hernandez, P. C. Pillow, H. B. Grossman, and X. Wu
Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study
Carcinogenesis,
September 1, 2004;
25(9):
1639 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Cicek, N. L. Nock, L. Li, D. V. Conti, G. Casey, and J. S. Witte
Relationship between Methylenetetrahydrofolate Reductase C677T and A1298C Genotypes and Haplotypes and Prostate Cancer Risk and Aggressiveness
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2004;
13(8):
1331 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gemmati, A. Ongaro, G. L. Scapoli, M. Della Porta, S. Tognazzo, M. L. Serino, E. Di Bona, F. Rodeghiero, G. Gilli, R. Reverberi, et al.
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin's Lymphoma in Adults
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2004;
13(5):
787 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sharp and J. Little
Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review
Am. J. Epidemiol.,
March 1, 2004;
159(5):
423 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kimura, K. Umegaki, M. Higuchi, P. Thomas, and M. Fenech
Methylenetetrahydrofolate Reductase C677T Polymorphism, Folic Acid and Riboflavin Are Important Determinants of Genome Stability in Cultured Human Lymphocytes
J. Nutr.,
January 1, 2004;
134(1):
48 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krajinovic, S. Lamothe, D. Labuda, E. Lemieux-Blanchard, Y. Theoret, A. Moghrabi, and D. Sinnett
Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia
Blood,
January 1, 2004;
103(1):
252 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. van Engeland, M. P. Weijenberg, G. M. J. M. Roemen, M. Brink, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, S. B. Baylin, A. F. P. M. de Goeij, and J. G. Herman
Effects of Dietary Folate and Alcohol Intake on Promoter Methylation in Sporadic Colorectal Cancer: The Netherlands Cohort Study on Diet and Cancer
Cancer Res.,
June 15, 2003;
63(12):
3133 - 3137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Robien and C. M. Ulrich
5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Leukemia Risk: A HuGE Minireview
Am. J. Epidemiol.,
April 1, 2003;
157(7):
571 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Gris, E. Mercier, I. Quere, and M. Dauzat
Association between the methylenetetrahydrofolate reductase 677C>T polymorphism and the risk of secondary lymphoproliferative disease in patients with a first idiopathic thrombosis
Blood,
June 28, 2002;
100(2):
735 - 736.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matsuo, R. Suzuki, Y. Morishima, N. Hamajima, C. M. Ulrich, R. Storb, M. M. Schubert, and J. D. Potter
Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification
Blood,
October 1, 2001;
98(7):
2283 - 2283.
[Full Text]
[PDF]
|
 |
|
|
|